112 related articles for article (PubMed ID: 34761111)
1. The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia.
Shen Y; Wang Z; Zhou F; Jin R
Open Life Sci; 2021; 16(1):1203-1212. PubMed ID: 34761111
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the
Guo Q; Sun JL; Li R; Li X
Int J Gen Med; 2024; 17():1221-1231. PubMed ID: 38559593
[TBL] [Abstract][Full Text] [Related]
3. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia.
Zhou Y; He H; Ding L; Wang T; Liu X; Zhang M; Zhang A; Fu J
Eur J Pediatr; 2024 Feb; 183(2):581-590. PubMed ID: 37851084
[TBL] [Abstract][Full Text] [Related]
4. The effects of genetic polymorphism on toxicity and pharmacokinetics of methotrexate in Egyptian adult patients with leukaemia or lymphoma.
Shendy K; Abdelkawy K; Ali AA; Belal F; Abdelhakiem M; Magdy G; Anber N; Elbarbry F
Xenobiotica; 2024 Feb; 54(2):95-105. PubMed ID: 38381003
[TBL] [Abstract][Full Text] [Related]
5. Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis.
Liu B; Liu G; Liu B; Guo Y; Peng N; Li T
World J Surg Oncol; 2024 Jan; 22(1):19. PubMed ID: 38212758
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Roles of MTHFR (C677T and A1298C) and MMP-2 (-1306C>T ) Variations in Bladder Cancer Development.
Alkanli N; Ay A
Urol Res Pract; 2023 Jan; 49(1):33-39. PubMed ID: 37877836
[TBL] [Abstract][Full Text] [Related]
7. Detection of Methylene Tetrahydrofolate Reductase (MTHFR C677T) Mutation among Acute Lymphoblastic Leukemia in Sudanese Patients.
Mohieldeen WA; Ahmed A; Elmosaad YM; Suliman RS; Alfahed A; Hjazi A; Al Shmrany H; Hakami N; Hakami MA; Almotiri A; Waggiallah HA
Rep Biochem Mol Biol; 2023 Oct; 12(3):458-464. PubMed ID: 38618256
[TBL] [Abstract][Full Text] [Related]
8. Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients.
Zhu J; Wang Z; Sun X; Wang D; Xu X; Yang L; Du J; Zhou Z; Qi Y; Ma L
Front Pharmacol; 2024; 15():1358262. PubMed ID: 38464726
[TBL] [Abstract][Full Text] [Related]
9. Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia.
Karpa V; Kalinderi K; Fidani L; Tragiannidis A
Hematol Rep; 2023 Nov; 15(4):634-650. PubMed ID: 37987321
[TBL] [Abstract][Full Text] [Related]
10.
Membrive-Jiménez C; Vieira-Maroun S; Márquez-Pete N; Cura Y; Pérez-Ramírez C; Tercedor-Sánchez J; Jiménez-Morales A; Ramírez-Tortosa MDC
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37761008
[TBL] [Abstract][Full Text] [Related]
11. Comparison of noninvasive screening tools for hepatic fibrosis, association with methotrexate cumulative dose, and risk factors in psoriasis patients.
Lee JHM; Loo CH; Tan WC; Lee CK; Jamil A; Khor YH
Dermatol Ther; 2022 Jan; 35(1):e15203. PubMed ID: 34779102
[TBL] [Abstract][Full Text] [Related]
12. Targeting Folate Metabolism Is Selectively Cytotoxic to Glioma Stem Cells and Effectively Cooperates with Differentiation Therapy to Eliminate Tumor-Initiating Cells in Glioma Xenografts.
Okada M; Suzuki S; Togashi K; Sugai A; Yamamoto M; Kitanaka C
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769063
[TBL] [Abstract][Full Text] [Related]
13. A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML.
Webster JA; Robinson TM; Blackford AL; Warlick E; Ferguson A; Borrello I; Zahurak M; Jones RJ; Smith BD
Leuk Res; 2021 Dec; 111():106737. PubMed ID: 34768161
[TBL] [Abstract][Full Text] [Related]
14. Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
Ruperto N; Brunner HI; Synoverska O; Ting TV; Mendoza CA; Spindler A; Vyzhga Y; Marzan K; Grebenkina L; Tirosh I; Imundo L; Jerath R; Kingsbury DJ; Sozeri B; Vora SS; Prahalad S; Zholobova E; Butbul Aviel Y; Chasnyk V; Lerman M; Nanda K; Schmeling H; Tory H; Uziel Y; Viola DO; Posner HB; Kanik KS; Wouters A; Chang C; Zhang R; Lazariciu I; Hsu MA; Suehiro RM; Martini A; Lovell DJ;
Lancet; 2021 Nov; 398(10315):1984-1996. PubMed ID: 34767764
[TBL] [Abstract][Full Text] [Related]
15. Dual extrauterine ectopic pregnancy: double management.
Bhat CS; Reddy NS; Vembu R; Pandurangi M
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764105
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of potentially harmful multidrug interactions on medication lists of elderly ambulatory patients.
Anand TV; Wallace BK; Chase HS
BMC Geriatr; 2021 Nov; 21(1):648. PubMed ID: 34798832
[TBL] [Abstract][Full Text] [Related]
17. Pazopanib-induced severe acute liver injury: A case report.
Choi JW; Yoo JJ; Kim SG; Kim YS; Chin S
Medicine (Baltimore); 2021 Nov; 100(46):e27731. PubMed ID: 34797298
[TBL] [Abstract][Full Text] [Related]
18. Physicochemistry of Cereblon Modulating Drugs Determines Pharmacokinetics and Disposition.
Kong NR; Liu H; Che J; Jones LH
ACS Med Chem Lett; 2021 Nov; 12(11):1861-1865. PubMed ID: 34795877
[TBL] [Abstract][Full Text] [Related]
19. Janus kinases restrain chronic lymphocytic leukemia cells in patients on ibrutinib: Results of a phase II trial.
Spaner DE; Luo Y; Wang G; Gallagher J; Tsui H; Shi Y
Cancer Med; 2021 Dec; 10(24):8789-8798. PubMed ID: 34791813
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas.
Fleming M; Huang Y; Dotson E; Bond DA; Reneau J; Epperla N; Alinari L; Brammer J; Christian BA; Baiocchi RA; Maddocks K; Sawalha Y
Blood Adv; 2022 Jan; 6(2):460-472. PubMed ID: 34788387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
